Global Biosurgery Market
Opportunities and Forecasts, 2014 – 2022
No Of Pages: 115
Published Date: March 2016
Introduction to Biosurgery Market • Biosurgery Market report, published by Allied Market Research, forecasts that the global market is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% during the period 2014 - 2022. • Hemostatic and surgical sealing agents segment collectively held about half of the market share in 2015, which is expected to flourish over the forecast period. • The neuro and spine surgery application segment is likely to lead the biosurgery market throughout the study period.
• The biosurgery market is projected to grow at a substantial rate owing to rise in sport & spine-related injuries, per capita healthcare expenditure, rise in the number of surgeries due to increase in obese population along with lifestyle disorders and others. • Also, availability of multi-functional products would provide a lucrative market opportunity; for instance, apart from fibrins use as surgical sealants, it is also used as hemostatic agents to prevent excessive blood loss during cardiothoracic and orthopedic surgeries.
Introduction to Biosurgery Market • However, factors that would hamper the market growth are high cost associated with surgeries, stern regulatory environment for product approval, and growing popularity of minimally invasive surgeries. • The bone graft substitutes segment contributed to one-third share in the overall biosurgery market in 2015.
• This segment covers products such as cell-based matrices, bone morphogenetic proteins, demineralized bone matrix, and synthetic graft extenders. • However, surgical sealant agents segment is expected to grow at the highest growth rate during the forecast period because of the availability of multifunctional products. • The neuro- and spine surgery application segment is projected to dominate the market due to high penetration of bone graft substitute products usage in the surgeries. • Also, current biologics products are more popular compared to synthetic biosurgical products, and this trend is expected to continue during the analysis period.
Biosurgery Market Key Segments
Biosurgery Market
Product Type
Antiadhesive agents
Hemostatic agents
Source
Application
Orthopedic surgery
Neuro- Spine surgery
Biologics products
Synthetic products
Biosurgery Market Dynamics
➢ Drivers • Rising prevalence of chronic diseases and related surgeries • Rising geriatric and obese population • Technological advancements • Aggressive market strategies adopted by top players ➢ Restraints • High cost associated with surgeries • Strict regulation and reimbursement issues
• Lack of awareness in LAMEA region • Increasing popularity of minimally invasive surgeries
Key Benefits of Biosurgery Market ✓ A comprehensive analysis of factors that drive and restrict the growth of the global Biosurgery market is provided in this report. ✓ The study provides an in-depth analysis of this market with current trends and forecasts to elucidate the imminent investment pockets. ✓ The report provides a quantitative analysis from 2014 to 2022, which is likely to enable the stakeholders to capitalize on prevailing growth opportunities. ✓ Extensive analysis of this market, by component, helps in understanding the products that are currently used along with the variants which are expected to gain prominence in future. ✓ Competitive intelligence among top players helps in understanding the competitive scenario across different geographic locations and the strategies adopted by them to increase their market share across various regions.
Biosurgery Market By Geography
North America
Europe
Asia-Pacific
LAMEA
Key Players Operating in Biosurgery Market • Medtronic PLC • Baxter International Inc. • C. R. Bard Inc. • Johnson and Johnson • Stryker Corporation • Sanofi S.A. • Atrium Medical Corporation (Maquet Getinge Group) • Hemostasis LLC • CryoLife Inc.
• Kuros Bioscience.
Thank You!
For More Details Visit us at https://www.alliedmarketresearch.com/biosurgery-market
Follow Us On